{"id":"W2934146457","doi":"10.1177/1203475419840629","title":"Existing and Emerging Therapies for Cutaneous T-Cell Lymphoma","year":2019,"lang":"en","type":"review","venue":"Journal of Cutaneous Medicine and Surgery","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Brentuximab vedotin; Medicine; Mycosis fungoides; Alemtuzumab; CD52; Lymphomatoid papulosis; Nivolumab; CD30; Lymphoma; Monoclonal antibody therapy; Oncology; Bexarotene; Monoclonal antibody; Immunology; Pembrolizumab; Cutaneous T-cell lymphoma; Dermatology; Immunotherapy; Antibody; Immune system","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006519199,0.0004017938,0.0006463373,0.0007564818,0.0002775897,0.0008591171,0.0005509836,0.0006566935,0.005930858],"category_scores_gemma":[0.0006261038,0.0001101718,0.0005963092,0.0004037946,0.0003957445,0.001254097,0.0006402993,0.00271767,0.00193201],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004483465,"about_ca_system_score_gemma":0.0004115539,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002906091,"about_ca_topic_score_gemma":0.001087233,"domain_scores_codex":[0.9996796,0.00007193378,0.00003222104,0.00004571351,0.000127645,0.00004302266],"domain_scores_gemma":[0.9995914,0.0001175815,0.00007029818,0.0000219345,0.000124288,0.00007451839],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0003303874,0.0003478918,0.0006386422,0.004205128,0.0001108018,0.0005489305,0.00008113372,0.0002900812,0.009984425,0.006157868,0.03098801,0.9463168],"study_design_scores_gemma":[0.0002886774,0.0008058731,0.001809286,0.001810335,0.0002450134,0.002902697,0.0001045637,0.000621856,0.003451132,0.005057681,0.9828792,0.00002371505],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.005244678,0.975967,0.00277186,0.005436399,0.001621633,0.00004378368,0.00008925271,0.0001263544,0.008699104],"genre_scores_gemma":[0.0554909,0.9174622,0.00540907,0.008765328,0.003785505,0.0001120209,0.0004785088,0.00004532995,0.008451173],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.005930858,"threshold_uncertainty_score":0.01984072,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1304439562623827,"score_gpt":0.3945113606673101,"score_spread":0.2640674044049275,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}